Sukumar Nagendran - President and Head of R&D, Director at Taysha Gene Therapies, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President and Head of R&D, Director
Stock Symbol
TSHA on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Sukumar Nagendran since 4/23/2024

Holdings reported by Sukumar Nagendran for Taysha Gene Therapies, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 1.22M $2.75M $2.25 Jan 2, 2025 Direct
Employee Stock Option (right to buy) 864K Jan 2, 2024 Direct Common Stock
Employee Stock Option (right to buy) 325K Jan 2, 2025 Direct Common Stock

Transactions reported by Sukumar Nagendran for Taysha Gene Therapies, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.